Evidence map›Paper›PMID 36968126›Full record

ArticleACG case reports journal2023

Secondary Sclerosing Cholangitis After Emphysematous Cholecystitis.

Koji Takahashi, Hiroshi Ohyama, Yuichi Takiguchi, Yu Sekine, Shodai Toyama, Nana Yamada, Chihei Sugihara, Motoyasu Kan, Mayu Ouchi, Hiroki Nagashima and 5 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in ACG case reports journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Koji TakahashiDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.ORCID https://orcid.org/0000-0001-8134-8524
Hiroshi OhyamaDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yuichi TakiguchiDepartment of Medical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yu SekineDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Shodai ToyamaDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Nana YamadaDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Chihei SugiharaDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Motoyasu KanDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Mayu OuchiDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Hiroki NagashimaDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yotaro IinoDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yuko KusakabeDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Kohichiroh OkitsuDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Izumi OhnoDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Naoya KatoDepartment of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Chiba University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 64-year-old woman was diagnosed with emphysematous cholecystitis. An open cholecystectomy was performed immediately. After the cholecystectomy, jaundice and multiple bile duct strictures that were not present preoperatively appeared. The patient was diagnosed with sclerosing cholangitis secondary to emphysematous cholecystitis. Endoscopic biliary stenting and endoscopic biliary balloon dilatation were performed. However, jaundice did not improve. She developed candidemia 75 days after cholecystectomy. The patient died of multiple organ failures 92 days after cholecystectomy. Although rare, secondary sclerosing cholangitis occurred after emphysematous cholecystitis, and endoscopic treatment was ineffective in this case.

Indexed as

cholecystitissclerosing cholangitissecondary sclerosing cholangitis

Identifiers

PMID36968126
PMCPMC10036046
OpenAlexW4353061013

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.